Chicago Partners Investment »

Humacyte shares owned by Chicago Partners Investment

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Chicago Partners Investment from 13F filings

Historical chart of Chicago Partners Investment investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Chicago Partners Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Chicago Partners Investment

Quarter filed Position value Share count Share price at filing
2026-03-31 $26k 37k 0.70

More positions owned by Chicago Partners Investment

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
NVIDIA Corporation Put Option (NVDA)
Dimensional Etf Trust Us Equity Market (DFUS)
Apple (AAPL)
Enterprise Products Partners (EPD)
Vanguard Index Fds Growth Etf (VUG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Energy Transfer Com Ut Ltd Ptn (ET)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Vanguard Index Fds Small Cp Etf (VB)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)

View all positions for Chicago Partners Investment

Top funds holding Humacyte

BlackRock
Vanguard Group
Vanguard Capital Management
Antipodes Partners
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
State Street Corporation
UBS Group
Woodline Partners
AQR Capital Management
Susquehanna International
Vanguard Portfolio Management
Charles Schwab Investment Management
Northern Trust
Vanguard Fiduciary Trust

View all funds holding Humacyte